According to Bloomberg Businessweek (7/31/12), Bayer has said it paid approximately $400 million to settle approximately 1,900 lawsuits. That works out to an average of around $212,000 a lawsuit. This does not resolve all the Yasmin lawsuits, as Bayer reportedly faced more than 12,000 lawsuits concerning Yasmin. In addition to allegations about blood clots, Bayer faces allegations that Yasmin is linked to gall bladder problems. Furthermore, lawsuits claim Bayer misled women about the risks associated with the birth control.
The Yasmin and Yaz lawsuits are filed under case number 09-md-02100, US District Court, Southern District of Illinois.
On April 10, 2012, the US Food and Drug Administration (FDA) requested Bayer strengthen the warning labels on certain birth control products, to reflect data indicating that drosperinone—a synthetic hormone—could triple the risk of blood clots.
READ MORE YASMIN BIRTH CONTROL LEGAL NEWS
Studies reviewed by the FDA did not account for patient characteristics that could influence prescribing of the birth control. Those characteristics could increase the risk of blood clots, rather than the increase being due solely to the birth control itself.
Although two recent studies suggest an increased risk of blood clots and venous thrombolic events in women using certain birth control, other studies have found no such risk.